“But it could be a treatment option ... for repurposing existing drugs. Fampridine targets specific ion channels in nerve cells that previous research suggested might play a role in mental disorders.

“This was the first time it’s been shown that a drug can actually slow down aging ... “And the CDC projects that number will double by 2064 if a cure is not found,” said Chris Schneider ...

Schizophrenia, which affects about 1% of Americans ... enthusiasm for psychedelic-assisted therapy as a new mental health treatment, we need to remember how early and limited the data remains ...

MONTREAL, Canada -- Canada said Tuesday (Wednesday, Manila time) it has opened an investigation into the World Anti-Doping Agency (WADA) after receiving a complaint about how the organization ...

Global News Health Matters: Psychedelic drug use linked to schizophrenia, research shows Posted: November 13, 2024 | Last updated: November 13, 2024 The use of psychedelics is growing in ...

MONTREAL - Canada said it has opened an investigation into the World Anti-Doping Agency (WADA) after receiving a complaint about how the organisation handles biological samples from taken from ...

GLP-1 drugs may be able to treat alcohol and opioid addiction by influencing dopamine levels in the brain. Ozempic users have reported fewer cravings for alcohol, drugs and nicotine, along with food.

The drug, previously called KarXT, is an oral medication for the treatment of schizophrenia in adults. Cobenfy introduces a fundamentally new approach to treating schizophrenia by selectively ...

According to GlobalData’s expiry model, KarXT is forecast to reach an annual total of $2.81bn in the US by 2033. Karuna’s New Drug Application (NDA) for KarXT for the treatment of schizophrenia in ...

University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill Kolesar, dean of the UI College of Pharmacy, is working on a drug that ...

MONTREAL, Canada (AFP)— Canada said Tuesday it has opened an investigation into the World Anti-Doping Agency (WADA) after receiving a complaint about how the organisation handles biological ...

Shares of rival Bristol Myers, which received U.S. approval for its schizophrenia treatment in September, surged 10.2% to $59.66. Bristol and AbbVie's drug belong to a new class of treatments that ...